Patents by Inventor Mark M. Zukowski

Mark M. Zukowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5399283
    Abstract: A mutated subtilisin suitable for admixture to washing compositions and exhibiting substantially improved stability over naturally occurring Bacillus serine proteases is prepared by expressing a modified gene encoding subtilisin in Bacillus subtilis. A preferred subtilisin analog product differs from wild-type Bacillus alkaline proteases by having any amino acid, and preferably serine, at position 218 in place of asparagine. The product is preferably produced in a strain of B. subtilis which is mutated to block synthesis of endogenous proteases. The method of replacing an Asn or a Gly in an Asn-Gly sequence in order to improve pH and thermal stability may be applied to other sites in subtilisin and to other proteins as well.
    Type: Grant
    Filed: January 9, 1991
    Date of Patent: March 21, 1995
    Assignee: Amgen Inc.
    Inventors: Yitzhak Stabinsky, Mark M. Zukowski
  • Patent number: 5397705
    Abstract: A class of subtilisin analogs suitable for admixture to cleaning compositions and having improved stability over naturally occurring Bacillus subtilisins are prepared by expressing a modified gene encoding the subtilisin analog in Bacillus subtilis.
    Type: Grant
    Filed: March 25, 1992
    Date of Patent: March 14, 1995
    Assignee: Amgen Inc.
    Inventors: Mark M. Zukowski, Linda O. Narhi, Michael Levitt
  • Patent number: 5350690
    Abstract: This disclosure relates to a sucrose inducible expression system. The sucrose inducible expression system comprises a novel plasmid vector having a sacY gene of the sacS locus which binds to a transcription terminator to relieve transcription termination when introduced into a B. subtilis host microorganism.
    Type: Grant
    Filed: April 28, 1992
    Date of Patent: September 27, 1994
    Assignee: Amgen Inc.
    Inventor: Mark M. Zukowski
  • Patent number: 4914031
    Abstract: A class of subtilisin analogs suitable for admixture to cleaning compositions and having improved stability over naturally occurring Bacillus subtilisins are prepared by expressing a modified gene encoding the subtilisin analog in Bacillus subtilis. The subtilisin analogs are characterized as having a modified calcium binding site to improve calcium binding and either an Asn or a Gly replaced in any Asn-Gly sequences present in the subtilisin.
    Type: Grant
    Filed: April 10, 1987
    Date of Patent: April 3, 1990
    Assignee: Amgen, Inc.
    Inventors: Mark M. Zukowski, Yitzhak Stabinsky, Michael Levitt